CORNEA ASSOCIATES OF TEXAS
🇺🇸United States
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Safety & Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution
Phase 1
Completed
- Conditions
- Pellucid Marginal Corneal DegenerationCorneal DegenerationKeratoconusCorneal Ectasia
- First Posted Date
- 2020-12-14
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Cornea Associates of Texas
- Target Recruit Count
- 249
- Registration Number
- NCT04667572
- Locations
- 🇺🇸
Cornea Associates of Texas, Dallas, Texas, United States
Safety and Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution
Phase 1
Completed
- Conditions
- Corneal EctasiaCorneal DegenerationPellucid Marginal Corneal DegenerationKeratoconus
- First Posted Date
- 2019-11-26
- Last Posted Date
- 2022-10-19
- Lead Sponsor
- Cornea Associates of Texas
- Target Recruit Count
- 200
- Registration Number
- NCT04177082
- Locations
- 🇺🇸
Cornea Associates of Texas, Dallas, Texas, United States
News
No news found